MAPT and dementia: For instance,past work using flortaucipir found that tau positivity in the entorhinal cortex was 80.2% inAβ-positive dementia patients, 50.2% in Aβ-positive MCI patients, and 6.3% incognitively-unimpaired people (Ossenkoppele et al.,2021).